Physician profile
Mark Xenakis
NPI 1477586972
$798.93
in general payments reported to CMS, 2019-2025
16 companies · $58.24 in 2025
The $58.24 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.97 · 2020: $74.12 · 2021: $168 · 2022: $332 · 2023: $102 · 2025: $58.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $187.15 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $113.03 | 2020-2023 | |
| Irhythm Technologies, INC. | $109.02 | 2022 | |
| Cardiva Medical, INC. | $67.67 | 2022 | |
| Penumbra, INC. | $58.24 | 2025 | Indigo System |
| Medtronic, INC. | $46.90 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $35.83 | 2022 | |
| Teleflex LLC | $30.97 | 2023 | Guideliner |
| Pfizer INC. | $29.08 | 2019-2020 | |
| Inari Medical, INC. | $27.24 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $19.01 | 2020 | |
| Abbott Laboratories | $18.69 | 2021 | |
| Angiodynamics, INC. | $17.62 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.38 | 2022 | |
| Edwards Lifesciences Corporation | $15.29 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $5.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Xenakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.